Latest News

Late Breaking News Articles

Filter by:
Topic
Clear filter
LED sign that reads CAR T Cells
HOPA News Late Breaking News

Late-Breaking HOPA News: CAR-T Approval Updates

July 22, 2024

CAR-T approval updates show the treatment moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia

Medical illustration of male kidneys and bladder
HOPA News Late Breaking News

Late-Breaking HOPA News: EV-302 and CheckMate 901 Trials and Other Genitourinary Studies

December 13, 2023

In October of 2023, several practice-changing presentations about genitourinary cancers were made during the annual European Society for Medical Oncology (ESMO) Congress.

HOPA News Late Breaking News

Late-Breaking HOPA News: COMMANDS Study for Myelodysplastic Syndrome

November 28, 2023

The COMMANDS study was a phase 3, open-label, multicenter, randomized controlled trial. Patients were eligible for enrollment if they were 18 years or older, diagnosed with very low risk, low risk or intermediate risk MDS, ESA-naïve, and requiring red blo

Female reproductive organs
Late Breaking News

Late-Breaking HOPA News: RUBY5 and NRG GY018/Keynote-868 Trial

June 26, 2023

The use of molecular classification within endometrial cancer has continued to evolve with the incorporation of biomarker-driven therapy .

Tools and Resources Late Breaking News

Immune Checkpoint Inhibitors Make Great Strides in Hepatocellular Carcinoma

May 18, 2023

STRIDE presents an alternative first-line choice for patients with unresectable HCC with a manageable side effect profile and a 22% reduction in risk of death over sorafenib

colonoscopy image
HOPA News Late Breaking News

Late-Breaking HOPA News: Colorectal Cancer Screening Updates & Review of NordICC

March 24, 2023

The Nordic-European Initiative on Colorectal Cancer (NordICC) trial is the first randomized controlled trial (RCT) to evaluate efficacy of CRC screening on risk of CRC development and related death.

Tools and Resources Late Breaking News

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024

January 18, 2023

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024

Late Breaking News

Adapting Investigational Drug Services During a Pandemic

October 06, 2022

Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group